AmandaMichelleOlsonMD

Family Medicine • Nashville, TN

Physician

Join to view full profile

Are you Dr. Olson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 45 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
3601 The Vanderbilt Clinic
Nashville, TN 37232
Phone+1 615-322-3000
Is this information wrong?

Summary

Dr. Amanda Olson, MD is a board certified family physician in Nashville, Tennessee. She is currently licensed to practice medicine in Tennessee, Alabama, and South Carolina. She is affiliated with Vanderbilt University Medical Center.

Education & Training

Prisma Health/University of South Carolina SOM Columbia (Columbia)Residency, Family Medicine, 2011 - 2014
Wright State University Boonshoft School of MedicineClass of 2011

Certifications & Licensure

TN State Medical License 2014 - 2025
AL State Medical License 2020 - 2020
SC State Medical License 2011 - 2014
American Board of Family Medicine Family Medicine

Publications & Presentations

PubMed

177 citations
Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors
Todd Hopkins, Yan Shi, Luis E. Rodriguez, Larry R. Solomon, Cherrie K. Donawho, Enrico L. Digiammarino, Sanjay C. Panchal, Julie L. Wilsbacher, Wenqing Gao, Amanda Ols...> ;Molecular Cancer Research. 2015 Nov 1
12 citations
Pyrimidine-based tricyclic molecules as potent and orally efficacious inhibitors of wee1 kinase.
Yunsong Tong, Maricel Torrent, Alan S. Florjancic, Kenneth D. Bromberg, Fritz G. Buchanan, Debra Ferguson, Eric F. Johnson, Loren M. Lasko, David Maag, Philip J. Merta...> ;ACS Medicinal Chemistry Letters. 2015 Jan 8
16 citations
Discovery and SAR of orally efficacious tetrahydropyridopyridazinone PARP inhibitors for the treatment of cancer.
Gui-Dong Zhu, Jianchun Gong, Viraj B. Gandhi, Xuesong Liu, Yan Shi, Eric F. Johnson, Cherrie K. Donawho, Paul Ellis, Jennifer J. Bouska, Donald J. Osterling, Amanda M....> ;Bioorganic & Medicinal Chemistry. 2012 Aug 1
7 citations
Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases.
Michael L. Curtin, H. Robin Heyman, Robin R. Frey, Patrick A. Marcotte, Keith B. Glaser, James R. Jankowski, Terrance J. Magoc, Daniel H. Albert, Amanda M. Olson, Davi...> ;Bioorganic & Medicinal Chemistry Letters. 2012 Jul 15
14 citations
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase families.
Michael L. Curtin, Robin R. Frey, H. Robin Heyman, Niru B. Soni, Patrick A. Marcotte, Lori J. Pease, Keith B. Glaser, Terrance J. Magoc, Paul Tapang, Daniel H. Albert,...> ;Bioorganic & Medicinal Chemistry Letters. 2012 May 1
46 citations
Optimization of Phenyl-Substituted Benzimidazole Carboxamide Poly(ADP-Ribose) Polymerase Inhibitors: Identification of (S)-2-(2-Fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-be...
Thomas D. Penning, Gui-Dong Zhu, Jianchun Gong, Sheela A. Thomas, Viraj B. Gandhi, Xuesong Liu, Yan Shi, Vered Klinghofer, Eric F. Johnson, Chang H. Park, Elizabeth H....> ;Journal of Medicinal Chemistry. 2010 Apr 22
45 citations
Synthesis and evaluation of a new generation of orally efficacious benzimidazole-based poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors as anticancer agents.
Yunsong Tong, Jennifer J. Bouska, Paul A. Ellis, Eric F. Johnson, Joel D. Leverson, Xuesong Liu, Patrick A. Marcotte, Amanda M. Olson, Donald J. Osterling, Magdalena P...> ;Journal of Medicinal Chemistry. 2009 Oct 21
50 citations
Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)
Julie M. Miyashiro, Keith W. Woods, Chang H. Park, Xuesong Liu, Yan Shi, Eric F. Johnson, Jennifer J. Bouska, Amanda M. Olson, Yan Luo, Elizabeth H. Fry, Vincent L. Gi...> ;Bioorganic & Medicinal Chemistry Letters. 2009 Aug 1
175 citations
Discovery of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the Treatment of Cancer
Thomas D. Penning, Gui-Dong Zhu, Viraj B. Gandhi, Jianchun Gong, Xuesong Liu, Yan Shi, Vered Klinghofer, Eric F. Johnson, Cherrie K. Donawho, David Frost, Velitchka Bo...> ;Journal of Medicinal Chemistry. 2009 Jan 22
45 citations
Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer.
Thomas D. Penning, Gui-Dong Zhu, Viraj B. Gandhi, Jianchun Gong, Sheela A. Thomas, W. Lubisch, Roland Grandel, Wolfgang Wernet, Chang H. Park, Elizabeth H. Fry, Xueson...> ;Bioorganic & Medicinal Chemistry. 2008 Jul 15
19 citations
Identification of aminopyrazolopyridine ureas as potent VEGFR/PDGFR multitargeted kinase inhibitors.
Yujia Dai, Kresna Hartandi, Niru B. Soni, Lori J. Pease, David R. Reuter, Amanda M. Olson, Donald J. Osterling, Stella Z. Doktor, Daniel H. Albert, Jennifer J. Bouska,...> ;Bioorganic & Medicinal Chemistry Letters. 2008 Jan 1
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailability.
Tong Y, Przytulinska M, Tao Z, Bouska J, Stewart KD, Park C, Li G, Claiborne A, Kovar P, Chen Z, Merta PJ, Bui M, Olson A, Osterling D, Zhang H, Sham HL, Rosenberg SH,...> ;Bioorg. Med. Chem. Lett.. 2007-10-15
46 citations
Syntheses of Potent, Selective, and Orally Bioavailable Indazole-Pyridine Series of Protein Kinase B/Akt Inhibitors with Reduced Hypotension
Gui-Dong Zhu, Viraj B. Gandhi, Jianchun Gong, Sheela A. Thomas, Keith W. Woods, Xiaohong Song, T. Li, R.B. Diebold, Yan Luo, Xuesong Liu, Ran Guan, Klinghofer, Eric F....> ;Journal of Medicinal Chemistry. 2007 May 25
584 citations
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models
Cherrie K. Donawho, Yan Luo, Yanping Luo, Thomas D. Penning, Joy Bauch, Jennifer J. Bouska, Velitchka Bontcheva-Diaz, Bryan F. Cox, Theodore L. DeWeese, Larry E. Dille...> ;Clinical Cancer Research. 2007 May 1
130 citations
Discovery of N-(4 -(3 -Amino-1H-indazol-4-yl )phenyl)-N'-(2 -fluoro-5-methylphenyl )urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosi...
Yujia Dai, Kresna Hartandi, Zhiqin Ji, Asma A Ahmed, Daniel H. Albert, Joy Bauch, Jennifer J. Bouska, Peter F. Bousquet, George A. Cunha, Keith B. Glaser, Christopher ...> ;Journal of Medicinal Chemistry. 2007 Mar 8
Join now to see all

Hospital Affiliations

Vanderbilt University Medical CenterNashville, Tennessee